Details

Full Title

dsDNA viruses > Details

Child Classifications

Navigate with arrow keys, Enter to open

• C12N 2710/00021 Viruses as such, e.g. new isolates, mutants or their genomic sequences
• C12N 2710/00022 New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
• C12N 2710/00023 Virus like particles [VLP]
• C12N 2710/00031 Uses of virus other than therapeutic or vaccine, e.g. disinfectant
• C12N 2710/00032 Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
• C12N 2710/00033 Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
• C12N 2710/00034 Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
• C12N 2710/00041 Use of virus, viral particle or viral elements as a vector
• C12N 2710/00051 Methods of production or purification of viral material
• C12N 2710/00061 Methods of inactivation or attenuation
• C12N 2710/00071 Demonstrated in vivo effect
• C12N 2710/00088 for redistribution
• C12N 2710/10011 Adenoviridae
• C12N 2710/12011 Asfarviridae
• C12N 2710/14011 Baculoviridae
• C12N 2710/16011 Herpesviridae
• C12N 2710/18011 Nimaviridae
• C12N 2710/20011 Papillomaviridae
• C12N 2710/22011 Polyomaviridae, e.g. polyoma, SV40, JC
• C12N 2710/24011 Poxviridae